Showing results (551-560 of 1,650) with videos related to
Sort By:
Pageof 165
Hepatology International|August 12, 2009
New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune responseDilip Ratnam, Kumar VisvanathanHepatology International|August 12, 2009
Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis BTeerha PiratvisuthHepatology International|August 12, 2009
Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary reportS Rajindrajith, A S Dassanayake, J Hewavisenthi, et al.Hepatology International|August 12, 2009
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapyAngela Douglass, Karen Wallace, Matthew Koruth, et al.Hepatology International|August 12, 2009
Pathogenetic background for treatment of ascites and hepatorenal syndromeSøren Møller, Jens H Henriksen, Flemming BendtsenHepatology International|August 12, 2009
A 7-day profile of oxidative stress and antioxidant status in patients with acute liver failureVikram Bhatia, Payal Bhardwaj, Jessina Elikkottil, et al.Hepatology International|August 12, 2009
Procaine inhibits the proliferation and DNA methylation in human hepatoma cellsMotohisa Tada, Fumio Imazeki, Kenichi Fukai, et al.Hepatology International|August 12, 2009
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in ChinaGuangbi Yao, Chengwei Chen, Weilun Lu, et al.Hepatology International|August 12, 2009
Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in ChinaGuangbi Yao, Xiaqiu Zhou, Daozheng Xu, et al.Hepatology International|August 12, 2009
Role of viral factors in the natural course and therapy of chronic hepatitis BJia-Horng KaoPageof 165